NCT07233720 2025-11-18
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Recruiting
Clinical Trials
3 trialsNCT04668365 2025-04-25
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Phase 2 Suspended
NCT06427213 2024-05-23
This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma
Henan Cancer Hospital
Phase 2 Not yet recruiting